Investigación Cardiovascular
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublications in collaboration with researchers from Icahn School of Medicine at Mount Sinai (26)
2024
-
Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation
Journal of the Society for Cardiovascular Angiography and Interventions, Vol. 3, Núm. 2
-
Impact of gender in patients with device-related thrombosis after left atrial appendage closure – A sub-analysis from the multicenter EUROC-DRT-registry
Echocardiography, Vol. 41, Núm. 8
2023
-
Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis
International Journal of Cardiology
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent
Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 3, pp. 503-510
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 2, pp. 309-320
-
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 797-804
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041
2020
-
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry
IJC Heart and Vasculature, Vol. 31
-
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
Cardiovascular Revascularization Medicine, Vol. 21, Núm. 12, pp. 1542-1547
-
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration
International Journal of Cardiology, Vol. 307, pp. 17-23
-
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)
American Journal of Cardiology, Vol. 127, pp. 1-8
2019
-
Corrigendum to “Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry” [Int. J. Cardiol. 283 (2019) 67–72](S0167527318318412)(10.1016/j.ijcard.2019.01.053)
International Journal of Cardiology
-
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry
International Journal of Cardiology, Vol. 283, pp. 67-72
2018
-
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration
JACC: Cardiovascular Interventions, Vol. 11, Núm. 19, pp. 1969-1978
-
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation
Journal of Cardiac Failure, Vol. 24, Núm. 2, pp. 78-86
2015
-
Diagnostic accuracy of coronary ct for the quantification of the syntax score in patients with left main and/or 3-vessel coronary disease. Comparison with invasive angiography
International Journal of Cardiology, Vol. 182, pp. 549-556
2014
-
Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis
Heart, Vol. 100, Núm. 21, pp. 1688-1695
-
Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study
JACC: Cardiovascular Imaging, Vol. 7, Núm. 4, pp. 397-405